Veru completes enrollment in Phase 2b obesity combination drug trial

July 27, 2026 8:10 AM

Veru Inc. (NASDAQ: VERU) announced it has completed enrollment in its Phase 2b PLATEAU clinical trial, which exceeded its target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found